Investment Summary |
|
|---|---|
| Date | 2022-06-02 |
| Target | Vernal Biosciences |
| Sector | Life Science |
| Investor(s) | Ampersand Capital Partners |
| Deal Type | Venture |
SEARCH BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 71 of 86 |
| Sector: Life Science M&A | 35 of 43 |
| Type: Venture M&A Deals | 11 of 11 |
| State: Vermont M&A | 1 of 1 |
| Country: United States M&A | 60 of 70 |
| Year: 2022 M&A | 6 of 11 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-04-21 |
ALPCO
Salem, New Hampshire, United States ALPCO is an importer and distributor of immunoassay-based products for the North American life science markets. ALPCO is a provider of proprietary and distributed diagnostics solutions, with over 60 collaborating partners from around the globe. ALPCO was founded in 1990 and is based in Salem, New Hampshire. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-06-23 |
Vantage MedTech
Moonachie, New Jersey, United States Vantage MedTech is a provider of custom electromechanical and software solutions for the medical device industry. Vantage MedTech was founded in 1998 and is based in Moonachie, New Jersey. |
Buy | - |
